The cost of a disease targeted for elimination in Brazil : the case of schistosomiasis mansoni

• Autor(a) principal: Nascimento, Gilmara Lima
• Data de Publicação: 2019
• Outros Autores: Pegado, Helio Milani, Domingues, Ana Lúcia Coutinho, Ximenes, Ricardo Arraes de Alencar, Itria, Alexander, Cruz, Luciane Nascimento, Oliveira, Maria Regina Fernandes de
• Tipo de documento: Artigo
• Idioma: eng
• Título da fonte: Repositório Institucional da UnB
• Texto Completo: https://repositorio.unb.br/handle/10482/36255; https://doi.org/10.1590/0074-02760180347
• topic: Esquistossomose - Brasil; Custos de cuidados de saúde

BACKGROUND Schistosomiasis mansoni is a poverty-related parasitic infection that has a variety of clinical manifestations. We consider the disability and deaths caused by schistosomiasis unacceptable for a tool-ready disease. Its condition in Brazil warrants an analysis that will enable better understanding of the local health losses and contribute to the complex decision-making process. OBJECTIVE This study estimates the cost of schistosomiasis in Brazil in 2015. METHODS We conducted a cost of illness study of schistosomiasis mansoni in Brazil in 2015 based on a prevalence approach and from a societal perspective. The study included 26,499 schistosomiasis carriers, 397 hepatosplenic cases, 48 cases with the neurological form, 284 hospitalisations, and 11,368.26 years of life lost (YLL) of which 5,187 years are attributable to economically active age groups. RESULTS The total cost of schistosomiasis mansoni in Brazil was estimated to be US$ 41,7million in 2015 with 94.61% of this being indirect costs. CONCLUSIONS The economic burden of schistosomiasis mansoni in Brazil is high and results in the loss of productivity. Its persistence in Brazil is a challenge to public health and requires inter-sectorial interventions in areas such as indoor water supply, basic sanitation, and education.